HOMA-IR, a marker of insulin resistance calculated from fasting values of glucose and insulin, did not differ between patients of the different CD4 strata, suggesting that an aspect of the glycemic defect might involve defective insulin response to an oral challenge. The gene discussed is INS; the disease is Insulin resistance.